Largest online gastroenterology, hepatology and endoscopy education and training resource with histology, x-ray images, videos, gastro calculators, and MCQs.
(MedPage Today) — Regorafenib, a novel treatment for metastatic colorectal cancer, extended survival in patients who had failed standard treatment compared with placebo, according to maker Bayer HealthCare Pharmaceuticals.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.